Salt, Hot Water, and Silicon Compounds Tracing Massive Twin Disks

We report results of 0.05"-resolution observations toward the O-type proto-binary system IRAS 16547-4247 with the Atacama Large Millimeter/submillimeter Array (ALMA). We present dynamical and chemical structures of the circumbinary disk, circumstellar disks, outflows and jets, illustrated by multi-wavelength continuum and various molecular lines. In particular, we detect sodium chloride, silicon compounds, and vibrationally-excited water lines as probes of the individual protostellar disks at a scale of 100 au. These are complementary to typical hot-core molecules tracing the circumbinary structures on a 1000-au scale. The H2O line tracing inner-disks has an upper-state energy of Eu/k>3000K, indicating a high temperature of the disks. On the other hand, despite the detected transitions of NaCl, SiO, and SiS not necessarily having high upper-state energies, they are enhanced only in the vicinity of the protostars. We interpret that these molecules are the products of dust destruction, which only happens in the inner disks. This is the second detection of alkali metal halide in protostellar systems after the case of the disk of Orion Source I, and also one of few massive protostellar disks associated with high-energy transition water and silicon compounds. These new results suggest these "hot-disk" lines may be common in innermost disks around massive protostars, and have great potential for future research of massive star formation. We also tentatively find that the twin disks are counter-rotating, which might give a hint of the origin of the massive proto-binary system IRAS 16547-4247.Comment: 15 pages, 5 figures, 2 appendix figures. Published in ApJ Letter

Alcoholic liver disease: A current molecular and clinical perspective.

Heavy alcohol use is the cause of alcoholic liver disease (ALD). The ALD spectrum ranges from alcoholic steatosis to steatohepatitis, fibrosis, and cirrhosis. In Western countries, approximately 50% of cirrhosis-related deaths are due to alcohol use. While alcoholic cirrhosis is no longer considered a completely irreversible condition, no effective anti-fibrotic therapies are currently available. Another significant clinical aspect of ALD is alcoholic hepatitis (AH). AH is an acute inflammatory condition that is often comorbid with cirrhosis, and severe AH has a high mortality rate. Therapeutic options for ALD are limited. The established treatment for AH is corticosteroids, which improve short-term survival but do not affect long-term survival. Liver transplantation is a curative treatment option for alcoholic cirrhosis and AH, but patients must abstain from alcohol use for 6 months to qualify. Additional effective therapies are needed. The molecular mechanisms underlying ALD are complex and have not been fully elucidated. Various molecules, signaling pathways, and crosstalk between multiple hepatic and extrahepatic cells contribute to ALD progression. This review highlights established and emerging concepts in ALD clinicopathology, their underlying molecular mechanisms, and current and future ALD treatment options

Alcoholic liver disease: A current molecular and clinical perspective.

Heavy alcohol use is the cause of alcoholic liver disease (ALD). The ALD spectrum ranges from alcoholic steatosis to steatohepatitis, fibrosis, and cirrhosis. In Western countries, approximately 50% of cirrhosis-related deaths are due to alcohol use. While alcoholic cirrhosis is no longer considered a completely irreversible condition, no effective anti-fibrotic therapies are currently available. Another significant clinical aspect of ALD is alcoholic hepatitis (AH). AH is an acute inflammatory condition that is often comorbid with cirrhosis, and severe AH has a high mortality rate. Therapeutic options for ALD are limited. The established treatment for AH is corticosteroids, which improve short-term survival but do not affect long-term survival. Liver transplantation is a curative treatment option for alcoholic cirrhosis and AH, but patients must abstain from alcohol use for 6 months to qualify. Additional effective therapies are needed. The molecular mechanisms underlying ALD are complex and have not been fully elucidated. Various molecules, signaling pathways, and crosstalk between multiple hepatic and extrahepatic cells contribute to ALD progression. This review highlights established and emerging concepts in ALD clinicopathology, their underlying molecular mechanisms, and current and future ALD treatment options